The first 3D bioprinting centre of excellence in the nation was opened on Friday following an agreement reached in August between CELLINK, a pioneer in bioprinter development, and the Indian Institute of Science. It will concentrate on giving scientists the resources they need to enhance research in drug development, tissue engineering, and regenerative medicine.

According to a news release from IISc, the CoE, which will be based in the Institute′s Centre for BioSystems Science and Engineering (BSSE), will give researchers access to 3D bioprinting equipment, allowing them to move more quickly toward the ultimate objective of enhancing health outcomes.

Tomoko Bylund, head of sales at CELLINK, said that the centre offers cutting-edge, market-leading 3D bioprinting technology. These technologies will make substantial advances in research and the development of the future of healthcare.

Researchers will have access to CELLINK instruments located at the centre, such as the ″BIO X, BIO X6, and the BIONOVA X″

(Source: https://health.economictimes.indiatimes.com/news/industry/iisc-inaugurates-first-centre-of-excellence-for-3d-bioprinting/96128840)